CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
复制标题
DOI:
10.1016/s0264-410x(99)00443-0
复制
发表时间:
2000-03-17
期刊:
影响因子:
5.5
通讯作者:
Sajuthi, D
中科院分区:
文献类型:
--
作者:
Davis, HL;Suparto, I;Sajuthi, D
Oligonucleotides containing immunostimulatory CpG motifs (CpG ODN) have been shown to be potent Th1-type adjuvants far augmenting antigen-specific responses in mice against hepatitis B surface antigen (HBsAg), The hepatitis B virus (HBV) infects only humans and great apes and appears to exist among wad chimpanzees and orangutans, An outbreak of HBV among orangutans being rehabilitated for re-introduction to the jungle caused the death of several animals. A prophylactic vaccination program revealed that orangutans are quite hypo-responsive to a current commercial vaccine compared to results obtained previously in humans and chimpanzees. Addition of CpG ODN to hepatitis B vaccine greatly increased the seroconversion rate and the titers of antibody against HBsAg (anti-HBs). This is the first: demonstration of CpG DNA in a great ape and the results have important implications for the vaccination of humans against HBV and other diseases. (C) 2000 Elsevier Science Ltd. All rights reserved.